U.K. spends $3.9B on adverse reactions

A necessary evil? The U.K.'s National Health Service is spending around $3.9 billion annually to treat patients for adverse reactions to prescription drugs. Some 6.5 percent of hospital admissions, a think tank report found, were the result of a drug reaction--that's more than 1 million patients per year. And that doesn't include patients whose reactions happened when they were already in the hospital.

Now, the center-left Compass think tank that came up with these figures admits that not all of the expense could be eliminated. Some drug reactions will happen even if all risks are admitted and publicized. But, said investiator Zoe Gannon, "It is all about getting a balance betwen risk and benefit and we feel that the balance is wrong."

- see the Guardian's article

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.